Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
Species
- (2)
- (2)
- (6)
- (6)
- (6)
- (6)
- (2)
- (11)
- (1,863)
- (107)
- (1)
- (1)
- (4)
- (50)
- (1)
- (8)
- (2)
- (15)
- (1)
- (458)
- (8)
- (1)
- (28,395)
- (1)
- (8)
- (3)
- (15)
- (1)
- (3)
- (13)
- (1)
- (7)
- (1)
- (3)
- (2)
- (3)
- (4)
- (3)
- (2)
- (4)
- (3)
- (3)
- (4)
- (4)
- (2)
- (2)
- (2)
- (1)
- (4)
- (1)
- (30,139)
- (196)
- (27)
- (19)
- (17)
- (8)
- (4)
- (1)
- (3)
- (2)
- (6)
- (218)
- (4)
- (2)
- (1,043)
- (18)
- (2)
- (1)
- (2)
- (14)
- (1)
- (53)
- (2)
- (2)
- (2)
- (1)
- (42)
- (9)
- (44)
- (31)
- (2)
- (58)
- (4)
- (161)
- (178)
- (13)
- (12)
- (3)
- (8)
- (4)
- (156)
- (4)
- (3)
- (3)
- (2)
- (2)
- (2)
- (14)
- (30,025)
- (4)
- (4,517)
- (2)
- (4)
For Use With (Application)
- (2,853)
- (1)
- (28,534)
- (1)
- (65)
- (355)
- (5,924)
- (24)
- (1)
- (8)
- (2)
- (8)
- (21,453)
- (2)
- (2)
- (1)
- (2)
- (53)
- (2)
- (2)
- (2)
- (1)
- (2)
- (2)
- (3)
- (1)
- (1)
- (5)
- (1)
- (1)
- (248)
- (23,706)
- (1)
- (1)
- (1)
- (28)
- (3)
- (50,527)
- (489)
- (2)
- (4)
- (32)
- (720)
- (4)
- (3)
- (2)
- (1)
- (117)
- (3,932)
- (1,566)
- (3)
- (62)
- (7)
- (3)
- (4)
- (19,645)
- (23)
- (31)
- (19)
- (179)
- (16)
- (3)
- (115)
- (150)
- (97)
- (1)
- (15)
- (3)
- (1)
- (1,603)
- (1)
- (4)
- (1)
- (18)
- (35)
- (11)
- (2)
- (1)
- (2)
- (1)
- (9)
- (11)
- (2)
- (467)
- (1)
- (4,209)
- (4)
- (5)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (47,864)
- (5)
- (2)
- (1)
- (62)
- (4)
- (5)
- (3)
- (6)
- (1)
- (1)
- (8,167)
- (4)
- (4)
- (1)
- (12)
- (2)
- (4)
- (11)
- (5)
- (5)
- (1)
- (50,354)
- (406)
Recombinant
- (12)
- (67,610)
- (19)
Form
- (3)
- (3)
- (49,865)
- (7,112)
- (3,650)
- (144)
- (16)
- (3,406)
Conjugate
- (2)
- (66)
- (1)
- (4)
- (2)
- (10)
- (64)
- (1)
- (4)
- (4)
- (1)
- (408)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (4)
- (2)
- (100)
- (12)
- (2)
- (3)
- (2)
- (2)
- (1)
- (13)
- (677)
- (1)
- (2)
- (3)
- (46)
- (42,335)
- (3)
- (2)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Keyword Search:
Clear search
1
–
15
of
78,543
results
1
Promotions Available
Gibco™ Human FGF-basic (FGF-2/bFGF) (aa 10-155) Recombinant Protein
![]()
Gibco™ Human FGF-basic (FGF-2/bFGF) (aa 10-155) Recombinant Protein
Recombinant Protein
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | FGF2 |
| Molecular Weight (g/mol) | 17 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 ≤ 1.0 ng/mL; determined by the dose-dependent proliferation of BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human FGF-basic (FGF-2/bFGF) (aa 10-155) |
| Purification Method | Purified |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Protein Form | Recombinant, Ligand, Truncated |
| Biological Activity | ED50 ≤ 1.0 ng/mL; determined by the dose-dependent proliferation of BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Research Category | Neurobiology, Oncology, Stem Cell Research, Microbiology, Differentiation, Angiogenesis |
| Species | Human |
| Recombinant | Recombinant |
| Content And Storage | 4°C |
| Gene Symbol | FGF2 |
| Sequence | Human FGF-basic, amino acids 10-155 |
| Storage Requirements | 4°C |
| Protein Subtype | FGFs (Fibroblast Growth Factors) |
| Accession Number | P09038 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 2247 |
| Product Line | Gibco |
2
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-4 |
| Molecular Weight (g/mol) | 15.1 kDa |
| Gene Symbol | Il4 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MHKCDITLQE IIKTLNSLTE QKTLCTELTV TDIFAASKNT TEKETFCRAA TVLRQFYSHH EKDTRCLGAT AQQFHRHKQL IRFLKRLDRN LWGLAGLNSC PVKEANQSTL ENFLERLKTI MREKYSKCSS |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human IL-4 |
| Accession Number | P05112 |
| Regulatory Status | RUO |
| Gene Alias | B cell growth factor 1; B_cell stimulatory factor 1; B-cell growth factor 1; B-cell IgG differentiation factor; B-cell stimulatory factor 1; BCGF1; BCGF-1; binetrakin; BSF1; BSF-1; cytokine; H-IL-4; IGG1 induction factor; IL2; IL4; Il-4; Il4e12; ILN; Interleukin; interleukin 4; interleukin 4 variant 2; interleukin 4 variant IL-4 delta2; interleukin 4 variant IL-4 delta3; interleukin 4 variant IL-4 int2A; interleukin 4 variant IL-4 int3A; interleukin 4 variant IL-4 int3B; Interleukin4; interleukin-4; interleukin-4 precursor; lymphocyte stimulatory factor 1; MGC79402; M-IL-4; Pitrakinra |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of human TF-1 cells is ≤ 0.2 ng/ml, corresponding to a specific activity of ≥ 5 x 10^6 units/mg |
| Gene ID (Entrez) | 3565 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
3
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IGF1 |
| Molecular Weight (g/mol) | 7.6 kDa |
| Gene Symbol | IGF1 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | GPETLCGAEL VDALQFVCGD RGFYFNKPTG YGSSSRRAPQ TGIVDECCFR SCDLRRLEMY CAPLKPAKSA |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human IGF-I |
| Accession Number | P05019 |
| Regulatory Status | RUO |
| Gene Alias | C730016P09Rik; class 1 insulin-like growth factor I preproprotein; class 2 insulin-like growth factor I preproprotein; H-IGF-1; IBP1; IGF; IGF1; Igf-1; IGF1A; IGFI; Igf-I; IGFIa; IGF-IA; IGF-IB; insulin growth factor-1; Insulin like growth factor; insulin like growth factor 1; insulin-like growth factor 1; insulin-like growth factor 1 (somatomedin C); insulin-like growth factor I; insulin-like growth factor I (somatomedin C); insulin-like growth factor IB; mechano growth factor; MGF; M-IGF-1; OTTHUMP00000195084; prepro-IGF-I; prepro-insulin-like growth factor I; R-IGF-1; somatomedin; Somatomedin C; Somatomedin-C |
| Biological Activity | The ED50 was determined by a cell proliferation assay using FDC-P1 cells is ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg |
| Gene ID (Entrez) | 3479 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
4
Promotions Available
Gibco™ Human/Mouse/Rat BDNF Recombinant Protein, PeproTech®
![]()
Gibco™ Human/Mouse/Rat BDNF Recombinant Protein, PeproTech®
Recombinant Protein
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | BDNF |
| Molecular Weight (g/mol) | 27 kDa |
| Gene Symbol | BDNF |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MHSDPARRGE LSVCDSISEW VTAADKKTAV DMSGGTVTVL EKVPVSKGQL KQYFYETKCN PMGYTKEGCR GIDKRHWNSQ CRTTQSYVRA LTMDSKKRIG WRFIRIDTSC VCTLTIKRGR |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human/Mouse/Rat BDNF |
| Accession Number | P21237, P23363, P23560 |
| Regulatory Status | RUO |
| Gene Alias | abrineurin; ANON2; anorexia BDNF; Bdnf; BDNF precursor form; bdnf protein; brain derived neurothrophic factor; brain derived neurotrophic factor; brain-derived neurotrophic factor; BULN2; H-BDNF; neurotrophin; ProBDNF |
| Biological Activity | Determined by its ability to bind recombinant human TrkB Fc Chimera in a functional ELISA. |
| Gene ID (Entrez) | 12064, 24225, 627 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
5
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | VEGF-165 |
| Molecular Weight (g/mol) | 38.2 kDa |
| Gene Symbol | VEGFA |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human VEGF-165 |
| Accession Number | P15692 |
| Regulatory Status | RUO |
| Gene Alias | H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165 b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF |
| Biological Activity | Determined by its ability to stimulate the proliferation of human umbilical vein endothelial cells (HUVEC). The expected ED50 for this effect is 1.0-10.0 ng/ml |
| Gene ID (Entrez) | 7422 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
6
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human EGF |
| Purification Method | Purified |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Stem Cell Research, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | EGF |
| Storage Requirements | 4°C |
| Protein Subtype | EGF (Epidermal Growth Factor) |
| Accession Number | P01133 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 1950 |
| Product Line | Gibco |
7
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | TGF beta-3 |
| Molecular Weight (g/mol) | 25 kDa |
| Gene Symbol | TGFB3 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | ALDTNYCFRN LEENCCVRPL YIDFRQDLGW KWVHEPKGYY ANFCSGPCPY LRSADTTHST VLGLYNTLNP EASASPCCVP QDLEPLTILY YVGRTPKVEQ LSNMVVKSCK CS |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human TGF-beta 3 |
| Accession Number | P10600 |
| Regulatory Status | RUO |
| Gene Alias | ARVD; ARVD1; FLJ16571; H-TGF-b-3; LAP; Latency-associated peptide; LDS5; prepro-transforming growth factor beta-3; RNHF; TGF beta 3; Tgfb3; TGF-B3; Tgfb-3; TGF-beta3; TGF-beta-3; Transforming growth factor; transforming growth factor beta 3; transforming growth factor beta precursor; transforming growth factor beta-3; Transforming growth factor beta-3 proprotein; transforming growth factor, beta 3; transforming growth factor-beta3 |
| Biological Activity | The ED50 was determined by TGF-beta3's ability to inhibit the mouse IL-4-dependent proliferation of mouse HT-2 cells is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
| Gene ID (Entrez) | 7043 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
8
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | NGF |
| Molecular Weight (g/mol) | 27 kDa |
| Gene Symbol | NGF |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | SSSHPIFHRG EFSVCDSVSV WVGDKTTATD IKGKEVMVLG EVNINNSVFK QYFFETKCRD PNPVDSGCRG IDSKHWNSYC TTTHTFVKAL TMDGKQAAWR FIRIDTACVC VLSRKAVRRA |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human beta-NGF |
| Accession Number | P01138 |
| Regulatory Status | RUO |
| Gene Alias | B nerve growth factor; beta ngf; beta-nerve growth factor; BetaNGF; beta-NGF; bNGF; b-NGF; HSAN5; MGC161426; MGC161428; nerve growth factor; nerve growth factor (beta polypeptide); nerve growth factor, beta; nerve growth factor, beta polypeptide; nerve growth factor, beta subunit; NGF; NGF b; NGF β; Ngfb; NGFbeta; NGFβ; β nerve growth factor; β NGF; βNGF |
| Biological Activity | Determined by the dose-dependent stimulation of the proliferation of human TF-1 cells. The expected ED50 is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 4803 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
9
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | M-CSF |
| Molecular Weight (g/mol) | 36.4 kDa |
| Gene Symbol | Csf1 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MKEVSEHCSH MIGNGHLKVL QQLIDSQMET SCQIAFEFVD QEQLDDPVCY LKKAFFLVQD IIDETMRFKD NTPNANATER LQELSNNLNS CFTKDYEEQN KACVRTFHET PLQLLEKIKN FFNETKNLLE KDWNIFTKNC NNSFAKCSSR DVVTKP |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Mouse M-CSF |
| Accession Number | P07141 |
| Regulatory Status | RUO |
| Gene Alias | C87615; colony stimulating factor 1; colony stimulating factor 1 (macrophage); colony-stimulating factor-1 splice variant; CSF1; CSF-1; Csfm; H-MCSF; lanimostim; macrophage colony stimulating factor 1; macrophage colony stimulating factor alpha; macrophage colony stimulating factor beta; macrophage colony-stimulating factor; macrophage colony-stimulating factor 1; macrophage colony-stimulating factor beta; macrophage-colony stimulating factor alpha; MCSF; MCSF alpha; MCSFBETA; MGC31930; M-MCSF; op; osteopetrosis; Processed macrophage colony-stimulating factor 1 |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of the proliferation of M-NFS-60 cells is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 12977 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
10
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | PDGF-AA |
| Molecular Weight (g/mol) | 28.5 kDa |
| Gene Symbol | Pdgfa |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | SIEEAVPAV CKTRTVIYEI PRSQVDPTSA NFLIWPPCVE VKRCTGCCNT SSVKCQPSRV HHRSVKVAKV EYVRKKPKLK EVQVRLEEHL ECACATTSLN PDYREEDTGR PRESGKKRKR KRLKPT |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human PDGF-AA |
| Accession Number | P04085 |
| Regulatory Status | RUO |
| Gene Alias | H-PDGF-AA; PDGF A-chain; PDGF subunit A; PDGF1; PDGF-1; Pdgfa; PDGF-A; PDGFACP; platelet derived growth factor subunit A; platelet derived growth factor, alpha; Platelet-derived growth factor A chain; platelet-derived growth factor A-chain; platelet-derived growth factor alpha chain; platelet-derived growth factor alpha polypeptide; Platelet-derived growth factor subunit A; Rpa1 |
| Biological Activity | Determined by the dose-dependent stimulation of the proliferation of Balb/c 3T3 cells. The expected ED50 for this effect is 1.0-3.0 ng/ml |
| Gene ID (Entrez) | 5154 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
11
| Protein Family | Cytokines & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | TNF alpha |
| Molecular Weight (g/mol) | 17.5 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 0.05 ng/mL; determined by the dose-dependent cytotoxcity on L929 cells in the presence of actinomycin D. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human TNF-alpha |
| Purification Method | Purified |
| Gene Alias | APC1 protein; Cachectin; C-domain 1; C-domain 2; cTNF; DADB-70P7.1; DIF; ICD1; ICD2; Intracellular domain 1; Intracellular domain 2; N-terminal fragment; NTF; RATTNF; Tnf; TNF alpha; TNF superfamily; TNF α; TNF, macrophage-derived; TNF, monocyte-derived; TNFA; TNF-a; TNFalpha; TNF-alpha; Tnfsf1a; TNFSF2; TNFα; TNLG1F; Tumor necrosis factor; tumor necrosis factor (TNF superfamily, member 2); tumor necrosis factor alpha; tumor necrosis factor alpha (cachetin); tumor necrosis factor alpha precursor; tumor necrosis factor ligand 1F; tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor, membrane form; Tumor necrosis factor, soluble form; tumor necrosis factor-alpha; tumor necrosis factor-alpha precursor; tumor-necrosis factor; tumour necrosis factor |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 0.05 ng/mL; determined by the dose-dependent cytotoxcity on L929 cells in the presence of actinomycin D. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Immunology, Signal Transduction, Stem Cell Research, Inflammation, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | Tnf |
| Sequence | VRSSSRTPSD KPVAHVVANP QAEGQLQWLN RRANALLANG VELRDNQLVV PSEGLYLIYS QVLFKGQGCP STHVLLTHTI SRIAVSYQTK VNLLSAIKSP CQRETPEGAE AKPWYEPIYL GGVFQLEKGD RLSAEINRPD YLDFAESGQV YFGIIAL |
| Storage Requirements | 4°C |
| Protein Subtype | TNF (Tumor Necrosis Factor) |
| Accession Number | P01375 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 7124 |
| Product Line | Gibco |
12
| Accession Number | P01574 |
|---|---|
| Regulatory Status | RUO |
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Gene ID (Entrez) | 3456 |
| Formulation | Protein with no preservative |
| Gene Symbol | Ifnb1 |
| Sequence | MSYNLLGFLQ RSSNFQCQKL LWQLNGRLEY CLKDRMNFDI PEEIKQLQQF QKEDAALTIY EMLQNIFAIF RQDSSSTGWN ETIVENLLAN VYHQINHLKT VLEEKLEKED FTRGKLMSSL HLKRYYGRIL HYLKAKEYSH CAWTIVRVEI LRNFYFINRL TGYLRN |
| For Use With (Application) | Control,Bioactivity |
| Source | CHO cells |
| Recombinant | Recombinant |
| Name | Human IFN-beta |
13
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Gene Symbol | FGF10 |
| Sequence | MLGQDMVSPE ATNSSSSSFS SPSSAGRHVR SYNHLQGDVR WRKLFSFTKY FLKIEKNGKV SGTKKENCPY SILEITSVEI GVVAVKAINS NYYLAMNKKG KLYGSKEFNN DCKLKERIEE NGYNTYASFN WQHNGRQMYV ALNGKGAPRR GQKTRRKNTS AHFLPMVVHS |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Source | E. coli |
| Name | Human FGF-10 |
| Accession Number | O15520 |
| Regulatory Status | RUO |
| Gene Alias | AEY17; BB213776; FGF; Fgf10; FGF-10; Fibroblast growth factor; Fibroblast growth factor 10; Gsfaey17; Keratinocyte growth factor 2; produced by fibroblasts of urinary bladder lamina propria |
| Gene ID (Entrez) | 2255 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
14
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | GM-CSF |
| Molecular Weight (g/mol) | 14.6 kDa |
| Gene Symbol | CSF2 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MAPARSPSPS TQPWEHVNAI QEARRLLNLS RDTAAEMNET VEVISEMFDL QEPTCLQTRL ELYKQGLRGS LTKLKGPLTM MASHYKQHCP PTPETSCATQ IITFESFKEN LKDFLLVIPF DCWEPVQE |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human GM-CSF |
| Accession Number | P04141 |
| Regulatory Status | RUO |
| Gene Alias | colony stimulating factor 2; colony stimulating factor 2 (granulocyte-macrophage); colony-stimulating factor; CSF; CSF2; Csfgm; cytokine; GMCSF; Gm-CSf; granulocyte macrophage colony stimulating factor; granulocyte macrophage-colony stimulating factor; granulocyte-macrophage colony stimulating factor 2; granulocyte-macrophage colony-stimulating factor; MGC131935; MGC138897; MGC151255; MGC151257; MGI-IGM; M-GM-CSF; molgramostin; put. GM-CSF; sargramostim |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 1437 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
15
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | GM-CSF |
| Molecular Weight (g/mol) | 14.2 kDa |
| Gene Symbol | CSF2 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MAPTRSPITV TRPWKHVEAI KEALNLLDDM PVTLNEEVEV VSNEFSFKKL TCVQTRLKIF EQGLRGNFTK LKGALNMTAS YYQTYCPPTP ETDCETQVTT YADFIDSLKT FLTDIPFECK KPVQK |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Mouse GM-CSF |
| Accession Number | P01587 |
| Regulatory Status | RUO |
| Gene Alias | colony stimulating factor 2; colony stimulating factor 2 (granulocyte-macrophage); colony-stimulating factor; CSF; CSF2; Csfgm; cytokine; GMCSF; Gm-CSf; granulocyte macrophage colony stimulating factor; granulocyte macrophage-colony stimulating factor; granulocyte-macrophage colony stimulating factor 2; granulocyte-macrophage colony-stimulating factor; MGC131935; MGC138897; MGC151255; MGC151257; MGI-IGM; M-GM-CSF; molgramostin; put. GM-CSF; sargramostim |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of the proliferation of murine FDC-P1 cells is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
| Gene ID (Entrez) | 12981 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |